Immunogenicity and protective efficacy of inactivated coxsackievirus B4 viral particles

Immunogenicity and protective efficacy of inactivated coxsackievirus B4 viral particles

ABSTRACTCoxsackievirus B4 (CVB4) is associated with a range of acute and chronic diseases such as hand, foot, and mouth disease, myocarditis, meningitis, pancreatitis, and type 1 diabetes, affecting millions of young children annually around the world. However, no vaccine is currently available for...

Full description

Bibliographic Details
Main Authors: Tingfeng Wang, Chiyuan Wang, Lili Pang, Yujie Zhang, Shuxia Wang, Xiaozhen Liang, Zhong Huang
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Emerging Microbes and Infections
Subjects:
Coxsackievirus B4
inactivated vaccine
E-particle
F-particle
neutralizing antibody
virus challenge
Online Access:https://www.tandfonline.com/doi/10.1080/22221751.2024.2337665

Similar Items

Similar Items